NEWT President Barry Sloane Acquires 11,000 Shares

Barry Sloane, the President, Chairman, and CEO of NEWT, made a significant move by purchasing 11,000 shares of the company on June 15, 2026. The shares were bought at an average price of $14.21 each, amounting to a total investment of $156,270.40. This transaction was not part of a pre-planned trading program.

Insider Buying and Selling at NEWT

In addition to Barry Sloane's purchase, other insiders have been active in acquiring NEWT shares. On June 3, 2026, Craig Jeffry Brunet bought 1,000 shares at $12.70 each. Earlier, Peter Mathison Downs, President of Newtek Bank, acquired 737 shares at $13.56 on May 26, 2026. Other notable transactions include Craig Jeffry Brunet's purchase of 330 shares at $12.72 on May 15, 2026, Gregory Zink's acquisition of 1,000 shares at $13.87 on May 8, 2026, and Richard Salute's purchase of 1,000 shares at $13.47 on May 7, 2026.

Other Institutional Activity in NEWT

Several institutional investors have also been adjusting their positions in NEWT. BlackRock, Inc. increased its holdings by 33,178 shares, bringing its total to 2,196,013 shares valued at approximately $24.05 million. Price T Rowe Associates Inc /MD/ significantly boosted its stake by 565,363 shares, ending with 922,469 shares worth about $10.10 million. Goldman Sachs Group Inc added 114,525 shares to hold a total of 663,764 shares valued at $7.27 million. Meanwhile, Vanguard Capital Management LLC initiated a position with 1,166,164 shares valued at $12.77 million, and Geode Capital Management, LLC increased its stake by 39,357 shares to a total of 657,346 shares worth $7.20 million.

Analysts Set New Price Targets

Analysts have maintained a cautious outlook on NEWT. On May 1, 2026, Keefe, Bruyette & Woods maintained their 'hold' rating with a $13.00 price target. Piper Sandler also maintained a 'hold' rating with a $14.00 target on February 9, 2026. The consensus recommendation remains 'hold', with an average price target reflecting analysts' cautious stance on the stock.

Bottom Line

Barry Sloane's recent purchase of NEWT shares reflects his confidence in the company. Investors often watch insider activity for potential signals about a company's future. While the insider buying is notable, it's important to remember that these trades are part of regular activity and may not predict future stock performance. Analysts continue to hold a neutral stance on NEWT, with price targets suggesting limited upside. As always, these insights are based on past data and should be considered as part of a broader investment strategy.